Your search returned 2 results.

Results
	1.	Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. [electronic resource] by Moreno-Montañés, Javier Sádaba, Belén Ruz, Verónica Gómez-Guiu, Almudena Zarranz, Javier González, María Victoria Pañeda, Covadonga Jimenez, Ana Isabel Producer: 20140813 In: Molecular therapy : the journal of the American Society of Gene Therapy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease. [electronic resource] by Benitez-Del-Castillo, José Manuel Moreno-Montañés, Javier Jiménez-Alfaro, Ignacio Muñoz-Negrete, Francisco José Turman, Krista Palumaa, Kadi Sádaba, Belén González, María Victoria Ruz, Verónica Vargas, Beatriz Pañeda, Covadonga Martínez, Tamara Bleau, Anne-Marie Jimenez, Ana Isabel Producer: 20170623 In: Investigative ophthalmology & visual science vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search